临床呼吸疾病与护理杂志：开放获取

The Mechanism of MSCs Therapy in Acute Respiratory Distress Syndrome

Abstract

Ying Wang, Cuicui Chen, Dongni Hou and Yuanlin Song

In past decades, acute respiratory distress syndrome (ARDS) has been associated with high mortality and morbidity. Although many maneuvers have been tested including tens of clinical trials, so far there is still no approved pharmacological intervention available for ARDS except protective ventilation strategy. Mesenchymal stem cells (MSCs) has shown improved survival in various ARDS animal model after administration. Here we summarized the updates of MSC derivation and purification, administration approaches, timing of MSC delivery, and mechanism of MSC therapy in order to provide a state-of-art paradigm of cell based therapy in ARDS and to facilitate the development of MSC therapy in ARDS patients.